{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T21:58:51Z","timestamp":1791496731980,"version":"4.3.4"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T00:00:00Z","timestamp":1707436800000},"content-version":"am","delay-in-days":314,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","lungcancerjournal.info","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Lung Cancer"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.lungcan.2023.01.016","type":"journal-article","created":{"date-parts":[[2023,2,4]],"date-time":"2023-02-04T11:13:22Z","timestamp":1675509202000},"page":"37-46","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Modulation of oxidative phosphorylation and mitochondrial biogenesis by cigarette smoke influence the response to immune therapy in NSCLC patients"],"prefix":"10.1016","volume":"178","author":[{"given":"Yuezhu","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jimmy","family":"Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory L.","family":"Kucera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umit","family":"Topaloglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael D.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wencheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6350-0764","authenticated-orcid":false,"given":"Fei","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.lungcan.2023.01.016_b0005","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/s41577-020-0306-5","article-title":"A guide to cancer immunotherapy: from T cell basic science to clinical practice","volume":"20","author":"Waldman","year":"2020","journal-title":"Nat. Rev. Immunol."},{"issue":"11","key":"10.1016\/j.lungcan.2023.01.016_b0010","doi-asserted-by":"crossref","first-page":"999","DOI":"10.2217\/imt-2018-0002","article-title":"An overview of cancer immunotherapeutic strategies","volume":"10","author":"Wahid","year":"2018","journal-title":"Immunotherapy"},{"issue":"4","key":"10.1016\/j.lungcan.2023.01.016_b0015","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1093\/annonc\/mdz011","article-title":"Five-year survival outcomes for patients with advanced melanoma treated with pembrolizumab in KEYNOTE-001","volume":"30","author":"Hamid","year":"2019","journal-title":"Ann. Oncol."},{"issue":"21","key":"10.1016\/j.lungcan.2023.01.016_b0020","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1056\/NEJMoa1501824","article-title":"Pembrolizumab for the treatment of non-small-cell lung cancer","volume":"372","author":"Garon","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"12","key":"10.1016\/j.lungcan.2023.01.016_b0025","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1056\/NEJMoa1816714","article-title":"Pembrolizumab plus axitinib versus sunitinib for advanced renal-cell carcinoma","volume":"380","author":"Rini","year":"2019","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.lungcan.2023.01.016_b0030","doi-asserted-by":"crossref","first-page":"e192535","DOI":"10.1001\/jamanetworkopen.2019.2535","article-title":"Estimation of the Percentage of US Patients With Cancer Who Are Eligible for and Respond to Checkpoint Inhibitor Immunotherapy Drugs","volume":"2","author":"Haslam","year":"2019","journal-title":"JAMA Netw. Open"},{"issue":"3","key":"10.1016\/j.lungcan.2023.01.016_b0035","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.immuni.2018.03.007","article-title":"Combination cancer therapy with immune checkpoint blockade: mechanisms and strategies","volume":"48","author":"Patel","year":"2018","journal-title":"Immunity"},{"issue":"2","key":"10.1016\/j.lungcan.2023.01.016_b0040","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1093\/annonc\/mdy551","article-title":"Enhancing antitumor response by combining immune checkpoint inhibitors with chemotherapy in solid tumors","volume":"30","author":"Heinhuis","year":"2019","journal-title":"Ann. Oncol."},{"issue":"2","key":"10.1016\/j.lungcan.2023.01.016_b0045","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.jhep.2019.09.025","article-title":"Challenges of combination therapy with immune checkpoint inhibitors for hepatocellular carcinoma","volume":"72","author":"Cheng","year":"2020","journal-title":"J. Hepatol."},{"issue":"3","key":"10.1016\/j.lungcan.2023.01.016_b0050","doi-asserted-by":"crossref","DOI":"10.3390\/cells9030561","article-title":"Myeloid-derived suppressor cells as a therapeutic target for cancer","volume":"9","author":"Law","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.lungcan.2023.01.016_b0055","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.canlet.2019.05.003","article-title":"Treg-mediated acquired resistance to immune checkpoint inhibitors","volume":"457","author":"Saleh","year":"2019","journal-title":"Cancer Lett."},{"issue":"3","key":"10.1016\/j.lungcan.2023.01.016_b0060","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/s41591-019-0382-x","article-title":"Genomic correlates of response to immune checkpoint blockade","volume":"25","author":"Keenan","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.lungcan.2023.01.016_b0065","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.3389\/fimmu.2019.01940","article-title":"The obesity paradox in cancer tumor immunology, and immunotherapy: potential therapeutic implications in triple negative breast cancer","volume":"10","author":"Naik","year":"2019","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.lungcan.2023.01.016_b0070","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s12957-020-1792-4","article-title":"Smokers or non-smokers: who benefits more from immune checkpoint inhibitors in treatment of malignancies? An up-to-date meta-analysis","volume":"18","author":"Mo","year":"2020","journal-title":"World J. Surg. Oncol."},{"issue":"1","key":"10.1016\/j.lungcan.2023.01.016_b0075","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s12964-020-00599-6","article-title":"Intestinal microbiota: a new force in cancer immunotherapy","volume":"18","author":"Dai","year":"2020","journal-title":"Cell Commun. Signal"},{"issue":"10","key":"10.1016\/j.lungcan.2023.01.016_b0080","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/nrc1190","article-title":"Tobacco carcinogens, their biomarkers and tobacco-induced cancer","volume":"3","author":"Hecht","year":"2003","journal-title":"Nat. Rev. Cancer"},{"issue":"3","key":"10.1016\/j.lungcan.2023.01.016_b0085","doi-asserted-by":"crossref","first-page":"220","DOI":"10.21037\/tlcr.2018.05.06","article-title":"The epidemiology of lung cancer","volume":"7","author":"de Groot","year":"2018","journal-title":"Transl. Lung Cancer Res."},{"issue":"5","key":"10.1016\/j.lungcan.2023.01.016_b0090","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/nri2530","article-title":"How cigarette smoke skews immune responses to promote infection, lung disease and cancer","volume":"9","author":"Stampfli","year":"2009","journal-title":"Nat. Rev. Immunol."},{"issue":"Suppl 6","key":"10.1016\/j.lungcan.2023.01.016_b0095","first-page":"19","article-title":"Effects of cigarette smoke on the lung and systemic immunity","volume":"59","author":"Domagala-Kulawik","year":"2008","journal-title":"J. Physiol. Pharmacol."},{"issue":"1","key":"10.1016\/j.lungcan.2023.01.016_b0100","doi-asserted-by":"crossref","first-page":"268","DOI":"10.18632\/oncotarget.13613","article-title":"Impacts of cigarette smoking on immune responsiveness: Up and down or upside down?","volume":"8","author":"Qiu","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.lungcan.2023.01.016_b0105","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jss.2018.07.007","article-title":"Common driver mutations and smoking history affect tumor mutation burden in lung adenocarcinoma","volume":"230","author":"Nagahashi","year":"2018","journal-title":"J. Surg. Res."},{"issue":"1","key":"10.1016\/j.lungcan.2023.01.016_b0110","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1093\/annonc\/mdy495","article-title":"Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic","volume":"30","author":"Chan","year":"2019","journal-title":"Ann. Oncol."},{"issue":"2","key":"10.1016\/j.lungcan.2023.01.016_b0115","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1183\/09031936.05.00095204","article-title":"Time course of cigarette smoke-induced pulmonary inflammation in mice","volume":"26","author":"D'Hulst","year":"2005","journal-title":"Eur. Respir. J."},{"issue":"3","key":"10.1016\/j.lungcan.2023.01.016_b0120","doi-asserted-by":"crossref","first-page":"L205","DOI":"10.1152\/ajplung.00330.2013","article-title":"Interrelated role of cigarette smoking, oxidative stress, and immune response in COPD and corresponding treatments","volume":"307","author":"Zuo","year":"2014","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"issue":"6","key":"10.1016\/j.lungcan.2023.01.016_b0125","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1158\/1078-0432.CCR-19-1769","article-title":"Effects of tobacco smoking on the tumor immune microenvironment in head and neck squamous cell carcinoma","volume":"26","author":"de la Iglesia","year":"2020","journal-title":"Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.lungcan.2023.01.016_b0130","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1046\/j.1365-2567.2003.01655.x","article-title":"Evidence for the immunosuppressive role of nicotine on human dendritic cell functions","volume":"109","author":"Nouri-Shirazi","year":"2003","journal-title":"Immunology"},{"issue":"2","key":"10.1016\/j.lungcan.2023.01.016_b0135","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.pharmthera.2005.10.015","article-title":"Oxidative stress in asthma and COPD: antioxidants as a therapeutic strategy","volume":"111","author":"Kirkham","year":"2006","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.lungcan.2023.01.016_b0140","doi-asserted-by":"crossref","first-page":"8416763","DOI":"10.1155\/2017\/8416763","article-title":"Oxidative stress: harms and benefits for human health","volume":"2017","author":"Pizzino","year":"2017","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"2","key":"10.1016\/j.lungcan.2023.01.016_b0145","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.immuni.2012.10.020","article-title":"Mitochondria are required for antigen-specific T cell activation through reactive oxygen species signaling","volume":"38","author":"Sena","year":"2013","journal-title":"Immunity"},{"issue":"6","key":"10.1016\/j.lungcan.2023.01.016_b0150","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S1074-7613(00)80072-2","article-title":"Reactive oxygen species regulate activation-induced T cell apoptosis","volume":"10","author":"Hildeman","year":"1999","journal-title":"Immunity"},{"issue":"5","key":"10.1016\/j.lungcan.2023.01.016_b0155","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.lungcan.2023.01.016_b0160","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.41351","article-title":"Mitochondrial fusion supports increased oxidative phosphorylation during cell proliferation","volume":"8","author":"Yao","year":"2019","journal-title":"Elife"},{"issue":"1","key":"10.1016\/j.lungcan.2023.01.016_b0165","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.cell.2019.08.012","article-title":"Proteomics of melanoma response to immunotherapy reveals mitochondrial dependence","volume":"179","author":"Harel","year":"2019","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.lungcan.2023.01.016_b0170","doi-asserted-by":"crossref","first-page":"241","DOI":"10.3109\/08923973.2010.521507","article-title":"Berlin grace, all trans retinoic acid and cancer","volume":"33","author":"Siddikuzzaman","year":"2011","journal-title":"Immunopharmacol. Immunotoxicol."},{"issue":"7","key":"10.1016\/j.lungcan.2023.01.016_b0175","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1093\/carcin\/21.7.1271","article-title":"Retinoids in chemoprevention and differentiation therapy","volume":"21","author":"Hansen","year":"2000","journal-title":"Carcinogenesis"},{"issue":"6","key":"10.1016\/j.lungcan.2023.01.016_b0180","doi-asserted-by":"crossref","first-page":"614","DOI":"10.4161\/cbt.308","article-title":"Treatment of acute promyelocytic leukemia with ATRA and As2O3: a model of molecular target-based cancer therapy","volume":"1","author":"Fang","year":"2002","journal-title":"Cancer Biol. Ther."},{"issue":"1\u20132","key":"10.1016\/j.lungcan.2023.01.016_b0185","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0304-3835(03)00108-3","article-title":"Retinoid therapy of high-risk neuroblastoma","volume":"197","author":"Reynolds","year":"2003","journal-title":"Cancer Lett."},{"issue":"6","key":"10.1016\/j.lungcan.2023.01.016_b0190","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1194\/jlr.M053652","article-title":"All-trans retinoic acid induces oxidative phosphorylation and mitochondria biogenesis in adipocytes","volume":"56","author":"Tourniaire","year":"2015","journal-title":"J. Lipid Res."},{"issue":"10","key":"10.1016\/j.lungcan.2023.01.016_b0195","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1038\/s41591-018-0136-1","article-title":"Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response","volume":"24","author":"Jiang","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.lungcan.2023.01.016_b0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2021.100990","article-title":"The effect of smoking status on efficacy of immune checkpoint inhibitors in metastatic non-small cell lung cancer: A systematic review and meta-analysis","volume":"38","author":"Dai","year":"2021","journal-title":"EClinicalMedicine"},{"issue":"4","key":"10.1016\/j.lungcan.2023.01.016_b0205","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1158\/1078-0432.CCR-14-3175","article-title":"Cancer neoantigens and applications for immunotherapy","volume":"22","author":"Desrichard","year":"2016","journal-title":"Clin. Cancer Res."},{"issue":"4","key":"10.1016\/j.lungcan.2023.01.016_b0210","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1007\/s11864-014-0305-5","article-title":"Immune checkpoint inhibitors in NSCLC","volume":"15","author":"Johnson","year":"2014","journal-title":"Curr. Treat. Options Oncol."},{"issue":"6230","key":"10.1016\/j.lungcan.2023.01.016_b0215","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1126\/science.aaa1348","article-title":"Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer","volume":"348","author":"Rizvi","year":"2015","journal-title":"Science"},{"issue":"30","key":"10.1016\/j.lungcan.2023.01.016_b0220","doi-asserted-by":"crossref","first-page":"20813","DOI":"10.1074\/jbc.M114.575464","article-title":"Epidermal growth factor receptor (EGFR) signaling regulates global metabolic pathways in EGFR-mutated lung adenocarcinoma","volume":"289","author":"Makinoshima","year":"2014","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.lungcan.2023.01.016_b0225","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/oby.2007.104","article-title":"Retinoic acid treatment increases lipid oxidation capacity in skeletal muscle of mice","volume":"16","author":"Amengual","year":"2008","journal-title":"Obesity (Silver Spring)"},{"issue":"1","key":"10.1016\/j.lungcan.2023.01.016_b0230","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.immuni.2019.12.011","article-title":"Top 10 challenges in cancer immunotherapy","volume":"52","author":"Hegde","year":"2020","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.lungcan.2023.01.016_b0235","doi-asserted-by":"crossref","first-page":"e14","DOI":"10.4110\/in.2018.18.e14","article-title":"The role of reactive oxygen species in regulating T cell-mediated immunity and disease","volume":"18","author":"Yarosz","year":"2018","journal-title":"Immune Netw."},{"issue":"1","key":"10.1016\/j.lungcan.2023.01.016_b0240","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1038\/s41467-018-04686-8","article-title":"Mitochondrial reactive oxygen species regulate the induction of CD8(+) T cells by plasmacytoid dendritic cells","volume":"9","author":"Oberkampf","year":"2018","journal-title":"Nat. Commun."},{"issue":"8","key":"10.1016\/j.lungcan.2023.01.016_b0245","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11081191","article-title":"Reactive oxygen species in the tumor microenvironment: an overview","volume":"11","author":"Weinberg","year":"2019","journal-title":"Cancers (Basel)"},{"issue":"8","key":"10.1016\/j.lungcan.2023.01.016_b0250","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/s41422-020-0379-5","article-title":"Metabolic signaling in T cells","volume":"30","author":"Shyer","year":"2020","journal-title":"Cell Res."},{"issue":"2","key":"10.1016\/j.lungcan.2023.01.016_b0255","doi-asserted-by":"crossref","first-page":"400","DOI":"10.4049\/jimmunol.1701041","article-title":"Metabolic barriers to T Cell function in tumors","volume":"200","author":"Sugiura","year":"2018","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.lungcan.2023.01.016_b0260","doi-asserted-by":"crossref","DOI":"10.1172\/JCI140522","article-title":"Tobacco smoking induces metabolic reprogramming of renal cell carcinoma","volume":"131","author":"Reigle","year":"2021","journal-title":"J. Clin. Invest."},{"issue":"22","key":"10.1016\/j.lungcan.2023.01.016_b0265","doi-asserted-by":"crossref","first-page":"5110","DOI":"10.1158\/1078-0432.CCR-15-0375","article-title":"Reversal of warburg effect and reactivation of oxidative phosphorylation by differential inhibition of egfr signaling pathways in non-small cell lung cancer","volume":"21","author":"De Rosa","year":"2015","journal-title":"Clin. Cancer Res."},{"issue":"16","key":"10.1016\/j.lungcan.2023.01.016_b0270","doi-asserted-by":"crossref","first-page":"4482","DOI":"10.1158\/0008-5472.CAN-18-0117","article-title":"Enhanced glycolysis supports cell survival in EGFR-mutant lung adenocarcinoma by inhibiting autophagy-mediated EGFR degradation","volume":"78","author":"Kim","year":"2018","journal-title":"Cancer Res."},{"key":"10.1016\/j.lungcan.2023.01.016_b0275","doi-asserted-by":"crossref","unstructured":"T. Cascone, J.A. McKenzie, R.M. Mbofung, S. Punt, Z. Wang, C. Xu, L.J. Williams, C.A. Bristow, A. Carugo, M.D. Peoples, L. Li, T. Karpinets, L. Huang, S. Malu, C. Creasy, S.E. Leahey, J. Chen, Y. Chen, H. Pelicano, C. Bernatchez, Y.N.V. Gopal, T.P. Heffernan, J. Hu, J. Wang, R.N. Amaria, L.A. Garraway, P. Huang, P. Yang, Wistuba, II, S.E. Woodman, J. Roszik, R.E. Davis, M.A. Davies, J.V. Heymach, P. Hwu, W. Peng, Increased Tumor Glycolysis Characterizes Immune Resistance to Adoptive T Cell Therapy, Cell Metab 27(5) (2018) 977-987.e4.","DOI":"10.1016\/j.cmet.2018.02.024"},{"issue":"5","key":"10.1016\/j.lungcan.2023.01.016_b0280","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph15051033","article-title":"Tobacco smoke induces and alters immune responses in the lung triggering inflammation, allergy, asthma and other lung diseases: a mechanistic review","volume":"15","author":"Strzelak","year":"2018","journal-title":"Int. J. Environ. Res. Public Health"},{"issue":"5","key":"10.1016\/j.lungcan.2023.01.016_b0285","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.124989","article-title":"Tumor cell oxidative metabolism as a barrier to PD-1 blockade immunotherapy in melanoma","volume":"4","author":"Najjar","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.lungcan.2023.01.016_b0290","doi-asserted-by":"crossref","unstructured":"M. Bolis, G. Paroni, M. Fratelli, A. Vallerga, L. Guarrera, A. Zanetti, M. Kurosaki, S.K. Garattini, M. Gianni, M. Lupi, L. Pattini, M.M. Barzago, M. Terao, E. Garattini, All-Trans Retinoic Acid Stimulates Viral Mimicry, Interferon Responses and Antigen Presentation in Breast-Cancer Cells, Cancers (Basel) 12(5) (2020).","DOI":"10.3390\/cancers12051169"},{"key":"10.1016\/j.lungcan.2023.01.016_b0295","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.intimp.2018.08.007","article-title":"Targeting myeloid-derived suppressor cells using all-trans retinoic acid in melanoma patients treated with Ipilimumab","volume":"63","author":"Tobin","year":"2018","journal-title":"Int. Immunopharmacol."}],"container-title":["Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500223000466?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500223000466?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T13:04:40Z","timestamp":1759237480000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169500223000466"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":59,"alternative-id":["S0169500223000466"],"URL":"https:\/\/doi.org\/10.1016\/j.lungcan.2023.01.016","relation":{},"ISSN":["0169-5002"],"issn-type":[{"value":"0169-5002","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Modulation of oxidative phosphorylation and mitochondrial biogenesis by cigarette smoke influence the response to immune therapy in NSCLC patients","name":"articletitle","label":"Article Title"},{"value":"Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lungcan.2023.01.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}